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Abstract 
Background: Various treatments have been proposed to treat ectopic pregnancy, but 
their impact on future pregnancies is still the subject of controversy. 
Objective: The aim of this study is to compare the medical and surgical treatment 
methods and their impact on the subsequent fertility results and complications in 
women with a history of ectopic pregnancy. 
Materials and Methods: In this analytical, cross-sectional study, 370 women with 
the history of ectopic pregnancy, (treared with single dose of methotrexate or 
salpingectomy by laparotomy), that referred to Al-Zahra Hospital, Rasht, Guilan 
between 2009 to 2013 were enrolled. 147 women responded to the phone call. The 
age, the number of women that needed to drug for pregnancy, fertility rate and the 
fertility outcomes were studied. 
Result: 147 women responded to the call and between them, 114 women tried to get 
pregnant again after the ectopic pregnancy treatment. They were agreed to the 
participate in the study. The mean age of the patients was 28.56±5.63 yr. The 
fertility rates in the medical and the surgical groups were 56.6% and 47.61%, 
respectively (p=0.141). There were no significant differences in the poor 
consequences of pregnancy among the two groups; ectopic pregnancy (p=0.605), 
miscarriage (p=0.605), and prematuredelivery (p=0.648). 15.1% in the medicinal 
group and two patients 12.5% in the surgical group had received fertility treatment 
in order to get pregnant (p=0.135). There was no significant difference in two 
groups.  
Conclusion: It seems that surgical treatment depending on the underlying variables 
of each patient, can be used such as medical treatment, without worrying about its 
effect on fertility. 
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Introduction 
 
 pregnancy that occurs in any place 
other than the endometrial cavity is 
called ectopic pregnancy. The 
incidence of ectopic pregnancy in developed 
countries has increased by 2% recently. 
Ectopic pregnancy is the most prevalent 
cause of mortality in pregnant women during 
their first trimester. It is responsible for 10% of 
all mortality during pregnancy. The treatment 
for ectopic pregnancy can have a significant 
effect on the health and future fertility of the 
patients (1). For a long time, surgical 
treatment had been the standard treatment for 
ectopic pregnancy (1). But today, medical 
treatment with methotrexate is the preferred 
treatment for patients with hemodynamically 
stable conditions (2). This method involves 
less damage to the tube, as well as lower 
costs, and it eliminates the risky effects of 
anesthesia and surgery. Various studies have 
reported different results in relation to the 
fertility status of medical and surgical 
treatment methods (3). There is a lack of 
studies in Iran that compare pregnancy 
outcomes in patients who were treated for 
ectopic pregnancy with a single dose of 
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methotrexate and patients who were treated 
by the surgical procedure. This study is 
designed to address that gap. 
 
Materials and methods 
 
This cross-sectional study analyzed the 
records of the patients who were admitted to 
the Al-Zahra Hospital with a diagnosis of 
ectopic pregnancy between 2009 and 2013. 
They were treated with either a single dose of 
methotrexate (50 mg/m2) or with the surgical 
(salpingectomy by laparotomy) method (4).  
The women who received surgical 
treatment in addition to the medicinal 
treatment, the women who have bilateral 
tubectomy during surgical treatment for 
ectopic pregnancy, the women who received 
multiple dose of methotrexate and who were 
cndidated for IVF or IUI in previous 
pregnancy, excluded from the study, other 
patient enrolled and were contacted by phone 
with them. 
 
Ethical consideration 
This study was approved by the Ethics 
Committee of the Guilan University of Medical 
Sciences (Code: 1910396401). Oral consent 
was obtained from all participants. 
 
Statistical analysis 
The data were analyzed with SPSS, 
software (Statistical Package for the Social 
Sciences, version 16.0 SPSS Inc., Chicago, 
USA). A Chi-square test was used to compare 
fertility and pregnancy outcomes in the two 
groups: those treated by medical treatment 
and those treated with the surgical procedure. 
 
Results 
 
In our study period, 370 women were 
treated for tubal pregnancy in the Al-Zahra 
Hospital (285 with a single dose of 
methotrexate and 85 with the tubal surgery). 
Of them 147 women responded to the call and 
114 women that tried to get pregnant again 
after the ectopic pregnancy treatment were 
agreed to the participate in the study. The 
mean age of the participitants was 
28.56(±5.63) yr with a minimum age 17 and a 
maximum 44 years.  
Of the 114 women, 21 patients (18.4%) 
had been treated with surgery, while 93 
patients (81.6%) had received the medicinal 
treatment. Out of the 114 patients, 71 
(62.28%) were pregnant. Within the medicinal 
treatment group, 61 patients (56.6%) were 
pregnant, while 10 patients (47.61%) were 
pregnant from the surgical treatment group. 
The pregnancy rate in the two groups was 
similar and had no significant difference 
(p=0.141), (table I). Also, there were no 
significant differences in the poor 
consequences of pregnancy; ectopic 
pregnancy (p=0.605), miscarriage (p=0.605), 
and prematuredelivery (p=0.648) among the 
two groups (Table II). 
A total of 14 patients (15.1%) in the 
medicinal group and two patients (12.5%) in 
the surgical group had received fertility 
treatment in order to get pregnant (p=0.135). 
 
Table I. Fertility rate after treatment of ectopic pregnancy in 
two study groups 
 Medical treatment 
group 
Surgical 
treatment group 
p-value 
Pregnancy 
Yes 61 (56.6) 10 (47.6) 
0.141 
No 32 (34.4) 11 (52.4) 
Total 93 (100) 21 (100)  
Data presented as n (%). Fisher’s exact test.  
 
 
Table II. Outcome of pregnancy after ectopic pregnancy 
treatment in two study groups 
 
Medical 
treatment group 
Surgical 
treatment group 
p-value 
Term 
pregnancy 
38 (62.2) 4 (40) 0.298 
Preterm 
pregnancy 
9 (14.8) 2 (20) 0.648 
Abortion 7 (11.5) 2 (20) 0.605 
Ectopic 
pregnancy 
7 (11.5) 2 (20) 0.605 
Total 61 (100) 10 (100)  
Data presented as n (%). Fisher’s exact test.  
Pregnancy in patients with a history of EP 
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Discussion 
 
The results of this study showed that the 
fertility rates are the same for the two groups. 
This finding is similar to the results of Ergo 
colleagues (5), but it contradicts the findings 
of De Bennetot (6) and Bouyer co-workers (7). 
Ergo and co-workers found that the fertility 
rate after one year depended on factors like 
age, a history of infertility, and damage to the 
anterior wall of the tube. The fertility rate, 
according to them, is not related to the type of 
treatment administered for ectopic pregnancy 
(5).  
De Bennetot et al studied the fertility rates 
in 164 women who were treated for ectopic 
pregnancy between 1992 and 2008 with 
surgical and medicinal procedures (6). The 
study found that the percentages of 
intrauterine pregnancy after two years of 
medicinal treatment (methotrexate) and 
surgery (salpingectomy), respectively, were 
76% and 67%. The rate of intrauterine 
pregnancy was higher in younger women who 
had been treated with the medicinal 
procedure. But it was found to be less in 
women older than 35 yr. 
In our study, the pregnancy rates after one 
year of treatment for ectopic pregnancy in 
medicinal and surgical patients were 56.6% 
and 47.6%, respectively. Bouyer et al. 
investigated the intrauterine pregnancy rate at 
18 months after treatment with methotrexate 
and surgical procedure and it was reported to 
be 80% and 57%, respectively (7). 
In a study by Khazardoost and co-workers, 
out of the 100 patients who were treated 
surgically, 74% experienced intrauterine 
pregnancy at least three years after surgery. 
This can probably be explained by the long-
term follow-up of the patients (8). 
In our study, the incidence of ectopic 
pregnancy was not statistically different 
between the two groups. This finding was 
similar to the studies of Bouyer and De 
Bennetot colleagues (6, 7). 
Conclusion 
 
In our study, the intrauterine pregnancy 
rate in patients treated with the medicinal and 
the surgical procedures was similar. However, 
the shortcomings of this study pertain to the 
low sample size and a short follow-up period 
of patients. Further study is needed to confirm 
or refute the findings of our study. Another 
limitation of our study was that laparoscopy 
and minimally-invasive procedures to maintain 
the tube were not used on any of the patients. 
Instead, salpingectomy was used. It is better 
to compare the fertility rate after medicinal 
therapy and non-invasive surgery by 
laparoscopy after an ectopic pregnancy. 
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